The Marketing Authorisations for Veterinary Medicinal Products (Revocation of Confidentiality Provision) Regulations 2004 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download The Marketing Authorisations for Veterinary Medicinal Products (Revocation of Confidentiality Provision) Regulations 2004 PDF full book. Access full book title The Marketing Authorisations for Veterinary Medicinal Products (Revocation of Confidentiality Provision) Regulations 2004 by Great Britain. Download full books in PDF and EPUB format.
Author: Great Britain
Publisher:
ISBN: 9780110507682
Category : Law
Languages : en
Pages :
Get Book Here
Book Description
Enabling power: European Communities Act 1972, s. 2 (2). Issued: 09.12.2004. Made: 02.12.2004. Laid: 06.12.2004. Coming into force: 01.01.2005. Effect: S.I. 1994/3142 amended. Territorial extent & classification: E/W/S/NI. General. Revoked by S.I. 2005/2745 (ISBN 0110734157)
Author: Great Britain
Publisher:
ISBN: 9780110507682
Category : Law
Languages : en
Pages :
Get Book Here
Book Description
Enabling power: European Communities Act 1972, s. 2 (2). Issued: 09.12.2004. Made: 02.12.2004. Laid: 06.12.2004. Coming into force: 01.01.2005. Effect: S.I. 1994/3142 amended. Territorial extent & classification: E/W/S/NI. General. Revoked by S.I. 2005/2745 (ISBN 0110734157)
Author: Great Britain
Publisher:
ISBN:
Category : Delegated legislation
Languages : en
Pages : 1040
Get Book Here
Book Description
Author: Great Britain. Parliament. House of Commons
Publisher:
ISBN:
Category : Great Britain
Languages : en
Pages : 412
Get Book Here
Book Description
Author: Great Britain. Parliament. House of Lords
Publisher:
ISBN:
Category : Great Britain
Languages : en
Pages : 488
Get Book Here
Book Description
Appendices accompany vols. 64, 67-71.
Author: John Talbot
Publisher: John Wiley & Sons
ISBN: 0470986344
Category : Medical
Languages : en
Pages : 751
Get Book Here
Book Description
Written with practitioners in mind, this new edition of Stephen’s Detection of Adverse Drug Reactions: Principle and Practice continues to be one of the corner stones of the pharmaceutical medicine list. The classic text covers the issues and problems involved in the detection of adverse drug reactions (ADRs) throughout the life cycle of a medicine from animal studies through to clinical trials, its introduction to the market, followed by wide clinical use, and eventual decline in use or withdrawal. The sixth edition is completely revised and updated including five new chapters on pharmacogenomics, ADRs with herbal medicines, safety of medical devices, safety issues with oncology drugs, and economic aspects of ADRs. All tables and web information needed in order to practice are included to make this sixth edition a complete primer for the new practitioner and a reference for the more experienced.
Author: World Health Organization
Publisher: Who Medical Device Technical
ISBN: 9789241501361
Category : Medical
Languages : en
Pages : 39
Get Book Here
Book Description
WHO and partners have been working towards devising an agenda, an action plan, tools and guidelines to increase access to appropriate medical devices. This document is part of a series of reference documents being developed for use at the country level. The series will include the following subject areas: * policy framework for health technology * medical device regulations * health technology assessment * health technology management * needs assessment of medical devices * medical device procurement * medical equipment donations * medical equipment inventory management * medical equipment maintenance * computerized maintenance management systems * medical device data * medical device nomenclature * medical devices by health-care setting * medical devices by clinical procedures * medical device innovation, research and development. These documents are intended for use by biomedical engineers, health managers, donors, nongovernmental organizations and academic institutions involved in health technology at the district, national, regional or global levels. HTA is the systematic evaluation of properties, effects, and/or impacts of health technology. Its main purpose is to inform technology-related policy-making in health care, and thus improve the uptake of cost-effective new technologies and prevent the uptake of technologies that are of doubtful value for the health system. It is one of three complementary functions to ensure the appropriate introduction and use of health technology. The other two components are regulation, which is concerned with safety and efficacy, and assessment of all significant intended as well as unintended consequences of technology use; and management, which is concerned with the procurement and maintenance of the technology during its life-cycle. The performance of health systems is strengthened when the linkages and exchange among these elements are clearly differentiated but mutually supportive. This document integrates health technology assessment into the WHO framework for evidence-informed policy-making. Health systems are strengthened when HTA is integrated into the human and material resources, data, transparent decision- and policy-making, and linked to the overall vision of equity and accountability. Good governance can rely on health technology assessment to provide a policy approach that is accountable for its decisions to the population.
Author: Maria Cristina Galli
Publisher: Springer
ISBN: 3319186183
Category : Medical
Languages : en
Pages : 235
Get Book Here
Book Description
This book discusses the different regulatory pathways for gene therapy (GT) and cell therapy (CT) medicinal products implemented by national and international bodies throughout the world (e.g. North and South America, Europe, and Asia). Each chapter, authored by experts from various regulatory bodies throughout the international community, walks the reader through the applications of nonclinical research to translational clinical research to licensure for these innovative products. More specifically, each chapter offers insights into fundamental considerations that are essential for developers of CT and GT products, in the areas of product manufacturing, pharmacology and toxicology, and clinical trial design, as well as pertinent "must-know" guidelines and regulations. Regulatory Aspects of Gene Therapy and Cell Therapy Products: A Global Perspective is part of the American Society of Gene and Cell Therapy sub-series of the highly successful Advances in Experimental Medicine and Biology series. It is essential reading for graduate students, clinicians, and researchers interested in gene and cell therapy and the regulation of pharmaceuticals.
Author: Great Britain: Parliament: House of Commons: Health Committee
Publisher: The Stationery Office
ISBN: 9780215024572
Category : Political Science
Languages : en
Pages : 556
Get Book Here
Book Description
Incorporating HC 1030-i to iii.
Author: World Intellectual Property Organization
Publisher: WIPO
ISBN: 9280523082
Category : Law
Languages : en
Pages : 259
Get Book Here
Book Description
This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.
Author: N. S. Atri
Publisher:
ISBN:
Category : Algae
Languages : en
Pages : 244
Get Book Here
Book Description
Contributed articles.
